Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Depreciation and Depletion (2016 - 2025)

Historic Depreciation and Depletion for Myriad Genetics (MYGN) over the last 12 years, with Q3 2025 value amounting to $4.8 million.

  • Myriad Genetics' Depreciation and Depletion changed 0.0% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.8 million, marking a year-over-year increase of 645.16%. This contributed to the annual value of $19.5 million for FY2024, which is 209.42% up from last year.
  • Myriad Genetics' Depreciation and Depletion amounted to $4.8 million in Q3 2025, which was down 0.0% from $4.9 million recorded in Q2 2025.
  • Myriad Genetics' 5-year Depreciation and Depletion high stood at $8.7 million for Q1 2023, and its period low was $2.6 million during Q3 2021.
  • Its 5-year average for Depreciation and Depletion is $4.0 million, with a median of $3.4 million in 2021.
  • Per our database at Business Quant, Myriad Genetics' Depreciation and Depletion soared by 21071.43% in 2023 and then crashed by 4367.82% in 2024.
  • Quarter analysis of 5 years shows Myriad Genetics' Depreciation and Depletion stood at $3.2 million in 2021, then fell by 3.12% to $3.1 million in 2022, then soared by 38.71% to $4.3 million in 2023, then increased by 16.28% to $5.0 million in 2024, then decreased by 4.0% to $4.8 million in 2025.
  • Its last three reported values are $4.8 million in Q3 2025, $4.9 million for Q2 2025, and $5.1 million during Q1 2025.